Media coverage
7
Media coverage
Title Bioxcel Therapeutics Announces Completion Of Patient Enrollment In Safety Portion Of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial Of BXCL701 In Combination With KEYTRUDA® Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 6/02/24 Persons Suresh Agarwal Title BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA® Media name/outlet ADVFN UK Country/Territory United Kingdom Date 6/02/24 URL https://uk.advfn.com/stock-market/NASDAQ/BTAI/share-news/BioXcel-Therapeutics-Announces-Completion-of-Patie/93214280 Persons Suresh Agarwal Title BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA® Media name/outlet Yahoo! Finance Country/Territory United States Date 6/02/24 URL https://finance.yahoo.com/news/bioxcel-therapeutics-announces-completion-patient-120000430.html Persons Suresh Agarwal Title BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA ‚ ® Media name/outlet Stockwatch Country/Territory Canada Date 6/02/24 URL www.stockwatch.com/News/Item/U-z9032674-U!BTAI-20240206/U/BTAI Persons Suresh Agarwal Title BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA® Media name/outlet Jotup Country/Territory United States Date 6/02/24 URL https://jotup.co/node/2735731 Persons Suresh Agarwal Title Completion of Patient Enrollment in Safety Portion of Investigator Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA Media name/outlet Market News Publishing Country/Territory United States Date 6/02/24 Persons Suresh Agarwal Title BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA® Media name/outlet GlobeNewswire Country/Territory United States Date 6/02/24 URL https://www.globenewswire.com/news-release/2024/02/06/2824137/0/en/BioXcel-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-Safety-Portion-of-Investigator-Sponsored-Phase-2-Relapsed-Pancreatic-Cancer-Trial-of-BXCL701-in-Combination-with-.html Persons Suresh Agarwal